insights_auto
Outlook: 63.3% bullish·3.3% bearish
Go to analysischevron_right
INO:NASDAQ
Inovio Pharmaceuticals Inc
1,48 US$
arrow_upward
+1,72%(+0,025) 1D
1,43 US$
arrow_downward
-3,05% (-0,045)bedtimeAfter hours
Closed: 11 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,37 US$
High
1,48 US$
Low
1,30 US$
Mkt. cap
249,17 მლნ.
Avg. vol.
18,79 მლნ.
Volume
10,58 მლნ.
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
Open
1,37 US$
High
1,48 US$
Low
1,30 US$
Mkt. cap
249,17 მლნ.
Avg. vol.
18,79 მლნ.
Volume
10,58 მლნ.
52-wk high
2,72 US$
52-wk low
0,57 US$
EPS
-1,17 US$
Beta
1,71
Shares outstanding
103,40 მლნ.
No. of employees
112
News stories
From web sources and news partners
GuruFocus
·
6 საათის წინ
INO Reiterated by Piper Sandler -- Price Target Lowered to $6.00
Yahoo Finance
·
8 საათის წინ
INOVIO to Participate in Upcoming Investor Conferences
GuruFocus
·
17 საათის წინ
FMR LLC Adds Inovio Pharmaceuticals Inc (INO) Shares -- Stock Looks 625% Overvalued on GF Value
Yahoo Finance
·
19 საათის წინ
Inovio Pharmaceuticals Q3 Earnings Call Highlights
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc